Tinnitus: network pathophysiology-network pharmacology
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Tinnitus, the phantom perception of sound, is a prevalent disorder. One in 10 adults has clinically significant subjective tinnitus, and for one in 100, tinnitus severely affects their quality of life. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single Food and Drug Administration (FDA)-approved drug on the market. The search for drugs that target tinnitus is hampered by the lack of a deep knowledge of the underlying neural substrates of this pathology. Recent studies are increasingly demonstrating that, as described for other central nervous system (CNS) disorders, tinnitus is a pathology of brain networks. The application of graph theoretical analysis to brain networks has recently provided new information concerning their topology, their robustness and their vulnerability to attacks. Moreover, the philosophy behind drug design and pharmacotherapy in CNS pathologies is changing from that of "magic bullets" that target individual chemoreceptors or "disease-causing genes" into that of "magic shotguns," "promiscuous" or "dirty drugs" that target "disease-causing networks," also known as network pharmacology. In the present work we provide some insight into how this knowledge could be applied to tinnitus pathophysiology and pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 3×
“…2001), airline transportation networks (Newman, 2003), metabolic, protein-protein interaction and gen interaction networks (Jeong et al., 2000; Podani et al., 2001; Ravasz et al., 2002; Wuchty et al., 2003; Almaas et al., 2004; Barabasi and Oltvai, 2004; Tong et al., 2004), to name a few.”
BackgroundSystems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Hierarchical Organization of Modularity in Metabolic Networks
Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., & Barabási, A.-L. (2002) · Science · doi:10.1126/science.1073374 · Cited by 4,224 · cited 1×
“…2001), airline transportation networks (Newman, 2003), metabolic, protein-protein interaction and gen interaction networks (Jeong et al., 2000; Podani et al., 2001; Ravasz et al., 2002; Wuchty et al., 2003; Almaas et al., 2004; Barabasi and Oltvai, 2004; Tong et al., 2004), to name a few.”
BackgroundMapping the structural core of human cerebral cortex
Hagmann, P., Cammoun, L., Gigandet, X., Meuli, R., Honey, C. J., Wedeen, V. J., & Sporns, O. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060159 · Cited by 4,173
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×
“Although the investment of pharmaceutical industries in research and development has grown from US$2 to $50 billion/year from 1980 to 2005 (Conn and Roth, 2008; Paul et al., 2010), the number of approved drugs per year, about 25, is not greater than 50 years ago.”
BackgroundClasses of small-world networks
Amaral, L. A. N., Scala, A., Barthélémy, M., & Stanley, H. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200327197 · Cited by 3,051 · cited 1×
“Many other small-world networks have exponential or exponentially truncated power law distributions, implying relatively reduced probabilities of huge hubs (Amaral et al., 2000; Albert and Barabasi, 2002).”
BackgroundExperimental and theoretical approaches to conscious processing
Dehaene, S., & Changeux, J.-P. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.018 · Cited by 2,573
Efficiency and Cost of Economical Brain Functional Networks
Achard, S., & Bullmore, E. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030017 · Cited by 2,553 · cited 4×
“Moreoever, these findings have been correlated with changes in the topology of the aging brain (Achard and Bullmore, 2007).”
BackgroundMethodInfluentialTowards a cognitive neuroscience of consciousness: basic evidence and a workspace framework
Dehaene, S. (2001) · Cognition · doi:10.1016/s0010-0277(00)00123-2 · Cited by 2,498 · cited 1×
“The global tinnitus network of long-range cortical connections resembles the global neuronal workspace model, where neurons distributed in distant cortical areas need to be accessed for conscious perception (Dehaene and Naccache, 2001; Baars, 2002, 2005).”
BackgroundBarabási, A.-L., & Bonabeau, E. (2003) · Scientific American · doi:10.1038/scientificamerican0503-60 · Cited by 2,494
Rich-club organization of the human connectome
van den Heuvel, M. P., & Sporns, O. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3539-11.2011 · Cited by 2,354
Large-scale recording of neuronal ensembles
Buzsáki, G. (2004) · Nature Neuroscience · doi:10.1038/nn1233 · Cited by 1,875 · cited 1×
“In addition, large scale multielectrode brain recordings in animals now offer unique opportunities to assay spatiotemporal patterns of neuronal assemblies in brain networks (Buzsaki, 2004; Lehew and Nicolelis, 2008).”
BackgroundPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · cited 3×
“A drug-target network linking drugs to their protein targets (Yildirim et al., 2007; Keiser et al., 2009) would help organize and visualize these data, define the target interplay for the different compounds and finally make predictions concerning the add-on effects that lidocaine has when compared…”
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Gong, G., He, Y., Concha, L., Lebel, C., Gross, D. W., Evans, A. C., & Beaulieu, C. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn102 · Cited by 1,112
The conscious access hypothesis: origins and recent evidence
Baars, B. J. (2002) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01819-2 · Cited by 994 · cited 1×
“The global tinnitus network of long-range cortical connections resembles the global neuronal workspace model, where neurons distributed in distant cortical areas need to be accessed for conscious perception (Dehaene and Naccache, 2001; Baars, 2002, 2005).”
The Temporal Structures and Functional Significance of Scale-free Brain Activity
He, B. J., Zempel, J. M., Snyder, A. Z., & Raichle, M. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.020 · Cited by 990 · cited 2×
“Two further studies that have used alternate analysis different from graph theory to EEG recordings, have also shown scale-free properties of brain activity: the analysis of fine temporal structures of arrhythmic brain activity by using nested-frequency EEG analysis (He et al., 2010) and EEG microstates (van de Ville…”
BackgroundTrends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853 · cited 1×
“In addition, there has not been much innovation (Rask-Andersen et al., 2011).”
BackgroundAdaptive reconfiguration of fractal small-world human brain functional networks
Bassett, D. S., Meyer-Lindenberg, A., Achard, S., Duke, T., & Bullmore, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606005103 · Cited by 814
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803 · cited 3×
“Moreover, it is sufficient that these multi-target drugs affect their targets only partially, which correlates with the low-affinity interactions of most drugs with several of their targets (Csermely et al., 2005).”
BackgroundMapping Human Whole-Brain Structural Networks with Diffusion MRI
Hagmann, P., Kurant, M., Gigandet, X., Thiran, P., Wedeen, V. J., Meuli, R., & Thiran, J.-P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000597 · Cited by 788 · cited 3×
“…in cortical gray matter thickness measured using MRI (He et al., 2007; Chen et al., 2008), DTI, and tractography of cortical and basal brain gray matter areas (Iturria-Medina et al., 2007, 2008; Gong et al., 2009) and diffusion spectrum imaging of cortical regions (Hagmann et al., 2007).”
BackgroundMethodMulticomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769 · cited 3×
“However, these problems can be reduced with polypharmacology, since it allows combination therapies at lower doses, resulting in higher efficacy and/or reduced side-effects compared to monotherapies (Morphy et al., 2004; Keith et al., 2005).”
BackgroundSystematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620 · cited 1×
“…drugs that contain two or more active ingredients formulated in the same delivery device, or a designer polypharmacology, e.g., a drug with two or more pharmacophores (Borisy et al., 2003; Morphy et al., 2004; Roth et al., 2004; Csermely et al., 2005; Keith et al., 2005; Hopkins, 2007, 2008).”
BackgroundEEG microstate sequences in healthy humans at rest reveal scale-free dynamics.
Van De Ville, D., Britz, J., & Michel, C. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007841107 · Cited by 606
Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits
Szabadics, J., Varga, C., Molnár, G., Oláh, S., Barzó, P., & Tamás, G. (2006) · Science · doi:10.1126/science.1121325 · Cited by 598
Understanding complexity in the human brain
Bassett, D. S., & Gazzaniga, M. S. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.03.006 · Cited by 572 · cited 1×
“Such is the case of the mind and of mind states like consciousness, emergent properties of the brain occurring between multiple physical and functional levels (Gazzaniga, 2010; Bassett and Gazzaniga, 2011).”
BackgroundStudying the human brain anatomical network via diffusion-weighted MRI and graph theory
Iturria-Medina, Y., Sotero, R. C., Canales-Rodríguez, E. J., Alemán-Gómez, Y., & Melie-García, L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.060 · Cited by 506
Can we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Cognitive effort drives workspace configuration of human brain functional networks
Kitzbichler, M. G., Henson, R. N. A., Smith, M. L., Nathan, P. J., & Bullmore, E. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0440-11.2011 · Cited by 427
Dehaene, S., & Changeux, J.-P. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030141 · Cited by 329 · cited 1×
“…during unconscious processing are suddenly replaced by the ignition of a globally synchronized network of neurons with long-range axons densely distributed in pre-frontal, parieto-temporal, and cingulate cortices, in response to a consciously attended stimulus (Dehaene and Changeux, 2005, 2011).”
BackgroundMultiple weak hits confuse complex systems: A transcriptional regulatory network as an example
Ágoston, V., Csermely, P., & Pongor, S. (2005) · Physical Review E · doi:10.1103/physreve.71.051909 · Cited by 111 · cited 5×
“Agoston and collaborators (Agoston et al., 2005), however, used an alternative approach, where they studied if the partial inactivation of several targets is more efficient than the complete inactivation of a single target.”
BackgroundResultInfluential
Cited by
Di Martino, A., Yan, C.-G., Li, Q., Denio, E., Castellanos, F. X., Alaerts, K., Anderson, J. S., Assaf, M., Bookheimer, S. Y., Dapretto, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.78 · Cited by 2,780
Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls
Arbabshirani, M. R., Plis, S., Sui, J., & Calhoun, V. D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.079 · Cited by 912
De Ridder, D., Vanneste, S., Weisz, N., Londero, A., Schlee, W., Elgoyhen, A. B., & Langguth, B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.021 · Cited by 398
Self-citationKnipper, M., Van Dijk, P., Nunes, I., Rüttiger, L., & Zimmermann, U. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.002 · Cited by 309
Therapeutic approaches to the treatment of tinnitus
Langguth, B., Elgoyhen, A. B., & Cederroth, C. R. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021556 · Cited by 129
Self-citation
Metadata
- Authors
- Elgoyhen, A. B., Langguth, B., Vanneste, S., & De Ridder, D.
- Venue
- Frontiers in Systems Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 6
- Pages
- 1-1
- ISSN
- 1662-5137 (ISSN-L)
- OpenAlex
- W2154829277
- Cited by
- 96
- References
- 32
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.